Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin
Journal of Pharmaceutical and Biomedical Analysis · 2025
DOI: 10.1016/j.jpba.2025.116994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2025. Verfasst von Monique Silva Dos Santos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Coordenação de Desenvolvimento Tecnológico, Instituto de Tecnologia em Fármacos (Farmanguinhos), Fundação Oswaldo Cruz, Rua Sizenando Nabuco, 100, Ri…. Hauptthemen laut MEDLINE: Rifampin, Isoniazid, Antitubercular Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State.
Abstract (Originalsprache)
Analytical Quality by Design (AQbD) is a proactive approach that ensures the consistent performance of analytical methods throughout the lifecycle. The application of AQbD in dissolution testing remains limited, particularly with the incorporation of measurement uncertainty to minimize risks for both consumers and producers. This study applied AQbD principles to develop a dissolution method for a fixed-dose combination of isoniazid (INH) and rifampicin (RIF) in dispersible tablets. The Analytical Target Profile was defined based on the dissolved percentage of INH and RIF. A risk-based approach was used to assess risks impacting the discriminative power and measurement uncertainty. design of experiments optimized medium pH, volume and rotation speed, considering two experimental batches. With Monte Carlo simulations, the Method Operable Design Region was constructed to allow batch A approval and batch B failure. Validation confirmed that the methods were selective, precise and accurate, with combined standard uncertainties of 1.7 % for INH and 3.8 % for RIF. The guard bands defined new acceptance limits in the three stages of dissolution, minimizing both consumer and producer risks. A hazard analysis and critical control point plan was established as a control strategy. If the dissolved percentage of RIF or INH leads to a batch failure, two options are possible: retesting or discarding the batch, considering guard bands to ensure a producer risk lower than 5 %. The study innovates by demonstrating the relevance of incorporating AQbD in dissolution testing, ensuring more reliable methods for controlling product quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Coordenação de Desenvolvimento Tecnológico, Instituto de Tecnologia em Fármacos (Farmanguinhos), Fundação Oswaldo Cruz, Rua Sizenando Nabuco, 100, Rio de Janeiro, RJ 21041-250, Brazil.
- Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Av. Prof. Lineu Prestes, 580, São Paulo, SP 05508-000, Brazil.
- Coordenação de Desenvolvimento Tecnológico, Instituto de Tecnologia em Fármacos (Farmanguinhos), Fundação Oswaldo Cruz, Rua Sizenando Nabuco, 100, Rio de Janeiro, RJ 21041-250, Brazil. Electronic address: liviaderis@gma…
Förderung
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State
Zitieren
APA
Dos Santos, M. S., do Nascimento, D. D., Medeiros, J. J. S., Lourenço, F. R., de Oliveira, C. A., & Prado, L. D. (2025). Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.116994
Vancouver
Dos Santos MS, do Nascimento DD, Medeiros JJS, Lourenço FR, de Oliveira CA, Prado LD. Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin. Journal of Pharmaceutical and Biomedical Analysis. 2025. doi:10.1016/j.jpba.2025.116994
BibTeX
@article{DosSantos2025,
author = {Dos Santos, Monique Silva and do Nascimento, Diogo Dibo and Medeiros, Juliana Johansson Soares and Lourenço, Felipe Rebello and de Oliveira, Camila Areias and Prado, Livia Deris},
title = {Analytical quality by design and measurement uncertainty in the development of discriminative dissolution method for pediatric fixed-dose combination dispersible tablets of isoniazid and rifampicin},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2025},
doi = {10.1016/j.jpba.2025.116994}
}
EUVIMED